Escitalopram
اسسیتالوپرام
🧠 Nervous SystemSSRI
Market / country: 🇺🇸 USA
Lexapro (US) · Cipralex (GB)
🧮 Dose calculator
Major depressive disorder · Regimen source: FDA Lexapro · Highlights — Dosage tableFDA Escitalopram · 2.1FDA Escitalopram · 8.4
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ MAOI (incl. linezolid or IV methylene blue) or within 14 days. FDA Escitalopram · 4
Warnings
- • Boxed warning (antidepressants): suicidal thoughts and behaviors in pediatric and young adult patients; monitor closely. FDA Lexapro · WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
Formulations
- 5 mg tablet — tablet 🇺🇸 USA FDA Escitalopram · 3
- 10 mg tablet — tablet 🇺🇸 USA FDA Escitalopram · 3
- 20 mg tablet — tablet 🇺🇸 USA FDA Escitalopram · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Escitalopram · 8.1
“Risk Summary Based on data from published observational studies, exposure to SSRIs, particularly in the month before delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage [see Warnings and Precautions (5.7) and Clinical Considerations] .”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Escitalopram · 8.2
“Risk Summary Data from the published literature report the presence of escitalopram and desmethylescitalopram in human milk (see Data ).”
- 👶 ChildrenDangerous / avoid
Boxed warning in the label about children. FDA Escitalopram · Boxed Warning
“Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Escitalopram · 8.5
“… significant hyponatremia in elderly patients, who may be at greater risk for this adverse reaction [see Warnings and Precautions ( 5.6 )].”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA078777
- DailyMed (FDA label)FDA EscitalopramFDA Lexapro
- MedlinePlus (NIH)Escitalopram
- WHO ATC/DDDN06AB10
- Darooyab (Iran)Escitalopram
🇮🇷 Registered in Iran Darooyab · G-583/Escitalopram
Dosage forms with Iranian generic codes, per Darooyab.
- 08968 · ESCITALOPRAM 10MG TAB · قرص اسسیتالوپرام ۱۰ میلیگرم
- 06484 · ESCITALOPRAM 20MG TAB · قرص اسسیتالوپرام ۲۰ میلیگرم
- 08455 · ESCITALOPRAM 5MG TAB · قرص اسسیتالوپرام ۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Escitalopram · 3FDA Lexapro · Highlights — Dosage tableFDA Escitalopram · 2.1FDA Escitalopram · 8.4FDA Lexapro · 2.2FDA Escitalopram · 2.2FDA Escitalopram · 4FDA Lexapro · WARNING: SUICIDAL THOUGHTS AND BEHAVIORSFDA Escitalopram · 8.1FDA Escitalopram · 8.2FDA Escitalopram · Boxed WarningFDA Escitalopram · 8.5FDA Escitalopram · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-583/Escitalopram
- Clinical review⚠ Unverified